nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketotifen—PDE4D—prostate cancer	0.592	1	CbGaD
Ketotifen—PDE7B—prostate gland—prostate cancer	0.00612	0.0832	CbGeAlD
Ketotifen—PDE8B—prostate gland—prostate cancer	0.00487	0.0663	CbGeAlD
Ketotifen—PDE7A—renal system—prostate cancer	0.00477	0.0649	CbGeAlD
Ketotifen—PDE8A—prostate gland—prostate cancer	0.00438	0.0596	CbGeAlD
Ketotifen—PDE4D—prostate gland—prostate cancer	0.00397	0.054	CbGeAlD
Ketotifen—PDE8A—seminal vesicle—prostate cancer	0.00371	0.0504	CbGeAlD
Ketotifen—PDE4A—prostate gland—prostate cancer	0.00351	0.0478	CbGeAlD
Ketotifen—PDE8A—urethra—prostate cancer	0.00293	0.0399	CbGeAlD
Ketotifen—PDE7B—testis—prostate cancer	0.00269	0.0367	CbGeAlD
Ketotifen—PGD—prostate gland—prostate cancer	0.00266	0.0362	CbGeAlD
Ketotifen—PGD—seminal vesicle—prostate cancer	0.00225	0.0306	CbGeAlD
Ketotifen—PDE8B—testis—prostate cancer	0.00215	0.0292	CbGeAlD
Ketotifen—PDE4B—prostate gland—prostate cancer	0.00209	0.0285	CbGeAlD
Ketotifen—PDE7B—lymph node—prostate cancer	0.00195	0.0266	CbGeAlD
Ketotifen—PDE8A—testis—prostate cancer	0.00193	0.0263	CbGeAlD
Ketotifen—PGD—renal system—prostate cancer	0.00181	0.0247	CbGeAlD
Ketotifen—PGD—urethra—prostate cancer	0.00178	0.0243	CbGeAlD
Ketotifen—PDE4D—testis—prostate cancer	0.00175	0.0238	CbGeAlD
Ketotifen—PDE8B—lymph node—prostate cancer	0.00156	0.0212	CbGeAlD
Ketotifen—PDE4A—testis—prostate cancer	0.00155	0.0211	CbGeAlD
Ketotifen—PDE4B—urethra—prostate cancer	0.0014	0.0191	CbGeAlD
Ketotifen—PDE8A—lymph node—prostate cancer	0.0014	0.019	CbGeAlD
Ketotifen—PGD—bone marrow—prostate cancer	0.00137	0.0187	CbGeAlD
Ketotifen—PDE4D—lymph node—prostate cancer	0.00127	0.0172	CbGeAlD
Ketotifen—HRH1—prostate gland—prostate cancer	0.0012	0.0164	CbGeAlD
Ketotifen—PGD—testis—prostate cancer	0.00117	0.016	CbGeAlD
Ketotifen—PDE4A—lymph node—prostate cancer	0.00112	0.0153	CbGeAlD
Ketotifen—PDE4B—bone marrow—prostate cancer	0.00108	0.0147	CbGeAlD
Ketotifen—PDE4B—testis—prostate cancer	0.000923	0.0126	CbGeAlD
Ketotifen—HRH1—epithelium—prostate cancer	0.000885	0.012	CbGeAlD
Ketotifen—PGD—lymph node—prostate cancer	0.00085	0.0116	CbGeAlD
Ketotifen—HRH1—urethra—prostate cancer	0.000806	0.011	CbGeAlD
Ketotifen—PDE4B—lymph node—prostate cancer	0.000669	0.0091	CbGeAlD
Ketotifen—Loratadine—CYP2C19—prostate cancer	0.000664	0.433	CrCbGaD
Ketotifen—HRH1—testis—prostate cancer	0.000531	0.00722	CbGeAlD
Ketotifen—Azatadine—CYP3A4—prostate cancer	0.000445	0.291	CrCbGaD
Ketotifen—Loratadine—CYP3A4—prostate cancer	0.000422	0.276	CrCbGaD
Ketotifen—HRH1—lymph node—prostate cancer	0.000385	0.00523	CbGeAlD
Ketotifen—Cystitis—Epirubicin—prostate cancer	0.000312	0.0018	CcSEcCtD
Ketotifen—Vomiting—Bicalutamide—prostate cancer	0.000306	0.00176	CcSEcCtD
Ketotifen—Rash—Bicalutamide—prostate cancer	0.000304	0.00175	CcSEcCtD
Ketotifen—Dermatitis—Bicalutamide—prostate cancer	0.000304	0.00175	CcSEcCtD
Ketotifen—Insomnia—Goserelin—prostate cancer	0.000303	0.00174	CcSEcCtD
Ketotifen—Headache—Bicalutamide—prostate cancer	0.000302	0.00174	CcSEcCtD
Ketotifen—Paraesthesia—Goserelin—prostate cancer	0.000301	0.00173	CcSEcCtD
Ketotifen—Insomnia—Conjugated Estrogens—prostate cancer	0.0003	0.00173	CcSEcCtD
Ketotifen—Dry eye—Epirubicin—prostate cancer	0.000299	0.00172	CcSEcCtD
Ketotifen—Paraesthesia—Conjugated Estrogens—prostate cancer	0.000298	0.00171	CcSEcCtD
Ketotifen—Somnolence—Goserelin—prostate cancer	0.000298	0.00171	CcSEcCtD
Ketotifen—Somnolence—Conjugated Estrogens—prostate cancer	0.000295	0.0017	CcSEcCtD
Ketotifen—Bladder pain—Epirubicin—prostate cancer	0.000293	0.00168	CcSEcCtD
Ketotifen—Cystitis noninfective—Doxorubicin—prostate cancer	0.000292	0.00168	CcSEcCtD
Ketotifen—Syncope—Estradiol—prostate cancer	0.000292	0.00168	CcSEcCtD
Ketotifen—Cystitis—Doxorubicin—prostate cancer	0.000289	0.00166	CcSEcCtD
Ketotifen—Pruritus—Ethinyl Estradiol—prostate cancer	0.000288	0.00166	CcSEcCtD
Ketotifen—Irritability—Prednisone—prostate cancer	0.000287	0.00165	CcSEcCtD
Ketotifen—Pain—Goserelin—prostate cancer	0.000287	0.00165	CcSEcCtD
Ketotifen—Nausea—Bicalutamide—prostate cancer	0.000286	0.00165	CcSEcCtD
Ketotifen—Loss of consciousness—Estradiol—prostate cancer	0.000286	0.00165	CcSEcCtD
Ketotifen—Pain—Conjugated Estrogens—prostate cancer	0.000284	0.00163	CcSEcCtD
Ketotifen—Hypertension—Estradiol—prostate cancer	0.000281	0.00162	CcSEcCtD
Ketotifen—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000279	0.0016	CcSEcCtD
Ketotifen—Dry eye—Doxorubicin—prostate cancer	0.000277	0.00159	CcSEcCtD
Ketotifen—Gastrointestinal pain—Goserelin—prostate cancer	0.000274	0.00158	CcSEcCtD
Ketotifen—Erythema multiforme—Etoposide—prostate cancer	0.000274	0.00158	CcSEcCtD
Ketotifen—Weight increased—Docetaxel—prostate cancer	0.000274	0.00158	CcSEcCtD
Ketotifen—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000272	0.00156	CcSEcCtD
Ketotifen—Dry mouth—Estradiol—prostate cancer	0.000271	0.00156	CcSEcCtD
Ketotifen—Bladder pain—Doxorubicin—prostate cancer	0.000271	0.00156	CcSEcCtD
Ketotifen—Dizziness—Ethinyl Estradiol—prostate cancer	0.000269	0.00155	CcSEcCtD
Ketotifen—Urticaria—Goserelin—prostate cancer	0.000266	0.00153	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Docetaxel—prostate cancer	0.000266	0.00153	CcSEcCtD
Ketotifen—Weight increased—Capecitabine—prostate cancer	0.000265	0.00153	CcSEcCtD
Ketotifen—Abdominal pain—Goserelin—prostate cancer	0.000265	0.00152	CcSEcCtD
Ketotifen—Body temperature increased—Goserelin—prostate cancer	0.000265	0.00152	CcSEcCtD
Ketotifen—Infection—Estradiol—prostate cancer	0.000264	0.00152	CcSEcCtD
Ketotifen—Urticaria—Conjugated Estrogens—prostate cancer	0.000264	0.00152	CcSEcCtD
Ketotifen—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000262	0.00151	CcSEcCtD
Ketotifen—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000262	0.00151	CcSEcCtD
Ketotifen—Hypertension—Mitoxantrone—prostate cancer	0.000262	0.00151	CcSEcCtD
Ketotifen—Shock—Estradiol—prostate cancer	0.000261	0.0015	CcSEcCtD
Ketotifen—Vomiting—Ethinyl Estradiol—prostate cancer	0.000259	0.00149	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Capecitabine—prostate cancer	0.000258	0.00148	CcSEcCtD
Ketotifen—Rash—Ethinyl Estradiol—prostate cancer	0.000257	0.00148	CcSEcCtD
Ketotifen—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000257	0.00148	CcSEcCtD
Ketotifen—Headache—Ethinyl Estradiol—prostate cancer	0.000255	0.00147	CcSEcCtD
Ketotifen—Epistaxis—Docetaxel—prostate cancer	0.000253	0.00146	CcSEcCtD
Ketotifen—Increased appetite—Epirubicin—prostate cancer	0.00025	0.00144	CcSEcCtD
Ketotifen—Infection—Mitoxantrone—prostate cancer	0.000246	0.00141	CcSEcCtD
Ketotifen—Epistaxis—Capecitabine—prostate cancer	0.000245	0.00141	CcSEcCtD
Ketotifen—Shock—Mitoxantrone—prostate cancer	0.000244	0.0014	CcSEcCtD
Ketotifen—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000242	0.00139	CcSEcCtD
Ketotifen—Nausea—Ethinyl Estradiol—prostate cancer	0.000242	0.00139	CcSEcCtD
Ketotifen—Hepatitis—Docetaxel—prostate cancer	0.000241	0.00139	CcSEcCtD
Ketotifen—Insomnia—Estradiol—prostate cancer	0.00024	0.00138	CcSEcCtD
Ketotifen—Paraesthesia—Estradiol—prostate cancer	0.000239	0.00137	CcSEcCtD
Ketotifen—Pruritus—Goserelin—prostate cancer	0.000237	0.00136	CcSEcCtD
Ketotifen—Somnolence—Estradiol—prostate cancer	0.000236	0.00136	CcSEcCtD
Ketotifen—Weight increased—Prednisone—prostate cancer	0.000236	0.00136	CcSEcCtD
Ketotifen—Pruritus—Conjugated Estrogens—prostate cancer	0.000235	0.00135	CcSEcCtD
Ketotifen—Hepatitis—Capecitabine—prostate cancer	0.000233	0.00134	CcSEcCtD
Ketotifen—Increased appetite—Doxorubicin—prostate cancer	0.000231	0.00133	CcSEcCtD
Ketotifen—Diarrhoea—Goserelin—prostate cancer	0.000229	0.00132	CcSEcCtD
Ketotifen—Erythema multiforme—Docetaxel—prostate cancer	0.000228	0.00131	CcSEcCtD
Ketotifen—Pain—Estradiol—prostate cancer	0.000227	0.00131	CcSEcCtD
Ketotifen—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000227	0.00131	CcSEcCtD
Ketotifen—Paraesthesia—Mitoxantrone—prostate cancer	0.000222	0.00128	CcSEcCtD
Ketotifen—Loss of consciousness—Etoposide—prostate cancer	0.000222	0.00128	CcSEcCtD
Ketotifen—Dizziness—Goserelin—prostate cancer	0.000222	0.00127	CcSEcCtD
Ketotifen—Erythema multiforme—Capecitabine—prostate cancer	0.000221	0.00127	CcSEcCtD
Ketotifen—Somnolence—Mitoxantrone—prostate cancer	0.00022	0.00127	CcSEcCtD
Ketotifen—Dizziness—Conjugated Estrogens—prostate cancer	0.00022	0.00126	CcSEcCtD
Ketotifen—Hypertension—Etoposide—prostate cancer	0.000218	0.00125	CcSEcCtD
Ketotifen—Gastrointestinal pain—Estradiol—prostate cancer	0.000217	0.00125	CcSEcCtD
Ketotifen—Vomiting—Goserelin—prostate cancer	0.000213	0.00123	CcSEcCtD
Ketotifen—Pain—Mitoxantrone—prostate cancer	0.000212	0.00122	CcSEcCtD
Ketotifen—Rash—Goserelin—prostate cancer	0.000211	0.00122	CcSEcCtD
Ketotifen—Dermatitis—Goserelin—prostate cancer	0.000211	0.00121	CcSEcCtD
Ketotifen—Vomiting—Conjugated Estrogens—prostate cancer	0.000211	0.00121	CcSEcCtD
Ketotifen—Urticaria—Estradiol—prostate cancer	0.000211	0.00121	CcSEcCtD
Ketotifen—Body temperature increased—Estradiol—prostate cancer	0.00021	0.00121	CcSEcCtD
Ketotifen—Abdominal pain—Estradiol—prostate cancer	0.00021	0.00121	CcSEcCtD
Ketotifen—Headache—Goserelin—prostate cancer	0.00021	0.00121	CcSEcCtD
Ketotifen—Rash—Conjugated Estrogens—prostate cancer	0.000209	0.0012	CcSEcCtD
Ketotifen—Dermatitis—Conjugated Estrogens—prostate cancer	0.000209	0.0012	CcSEcCtD
Ketotifen—Headache—Conjugated Estrogens—prostate cancer	0.000208	0.0012	CcSEcCtD
Ketotifen—Infection—Etoposide—prostate cancer	0.000205	0.00118	CcSEcCtD
Ketotifen—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000202	0.00116	CcSEcCtD
Ketotifen—Thrombocytopenia—Etoposide—prostate cancer	0.000202	0.00116	CcSEcCtD
Ketotifen—Nausea—Goserelin—prostate cancer	0.000199	0.00115	CcSEcCtD
Ketotifen—Nausea—Conjugated Estrogens—prostate cancer	0.000197	0.00113	CcSEcCtD
Ketotifen—Urticaria—Mitoxantrone—prostate cancer	0.000197	0.00113	CcSEcCtD
Ketotifen—Body temperature increased—Mitoxantrone—prostate cancer	0.000196	0.00113	CcSEcCtD
Ketotifen—Abdominal pain—Mitoxantrone—prostate cancer	0.000196	0.00113	CcSEcCtD
Ketotifen—Syncope—Docetaxel—prostate cancer	0.000188	0.00108	CcSEcCtD
Ketotifen—Pruritus—Estradiol—prostate cancer	0.000188	0.00108	CcSEcCtD
Ketotifen—Paraesthesia—Etoposide—prostate cancer	0.000185	0.00106	CcSEcCtD
Ketotifen—Weight increased—Epirubicin—prostate cancer	0.000185	0.00106	CcSEcCtD
Ketotifen—Loss of consciousness—Docetaxel—prostate cancer	0.000184	0.00106	CcSEcCtD
Ketotifen—Somnolence—Etoposide—prostate cancer	0.000183	0.00105	CcSEcCtD
Ketotifen—Syncope—Capecitabine—prostate cancer	0.000182	0.00105	CcSEcCtD
Ketotifen—Diarrhoea—Estradiol—prostate cancer	0.000182	0.00105	CcSEcCtD
Ketotifen—Hypertension—Docetaxel—prostate cancer	0.000181	0.00104	CcSEcCtD
Ketotifen—Drowsiness—Epirubicin—prostate cancer	0.000181	0.00104	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000179	0.00103	CcSEcCtD
Ketotifen—Loss of consciousness—Capecitabine—prostate cancer	0.000178	0.00103	CcSEcCtD
Ketotifen—Pain—Etoposide—prostate cancer	0.000176	0.00101	CcSEcCtD
Ketotifen—Dizziness—Estradiol—prostate cancer	0.000176	0.00101	CcSEcCtD
Ketotifen—Hypertension—Capecitabine—prostate cancer	0.000175	0.00101	CcSEcCtD
Ketotifen—Dry mouth—Docetaxel—prostate cancer	0.000175	0.001	CcSEcCtD
Ketotifen—Weight increased—Doxorubicin—prostate cancer	0.000171	0.000983	CcSEcCtD
Ketotifen—Epistaxis—Epirubicin—prostate cancer	0.000171	0.000982	CcSEcCtD
Ketotifen—Infection—Docetaxel—prostate cancer	0.00017	0.000978	CcSEcCtD
Ketotifen—Diarrhoea—Mitoxantrone—prostate cancer	0.000169	0.000974	CcSEcCtD
Ketotifen—Dry mouth—Capecitabine—prostate cancer	0.000169	0.000972	CcSEcCtD
Ketotifen—Vomiting—Estradiol—prostate cancer	0.000169	0.000972	CcSEcCtD
Ketotifen—Gastrointestinal pain—Etoposide—prostate cancer	0.000168	0.000969	CcSEcCtD
Ketotifen—Shock—Docetaxel—prostate cancer	0.000168	0.000968	CcSEcCtD
Ketotifen—Thrombocytopenia—Docetaxel—prostate cancer	0.000168	0.000964	CcSEcCtD
Ketotifen—Rash—Estradiol—prostate cancer	0.000168	0.000964	CcSEcCtD
Ketotifen—Drowsiness—Doxorubicin—prostate cancer	0.000167	0.000963	CcSEcCtD
Ketotifen—Dermatitis—Estradiol—prostate cancer	0.000167	0.000963	CcSEcCtD
Ketotifen—Headache—Estradiol—prostate cancer	0.000166	0.000957	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000166	0.000955	CcSEcCtD
Ketotifen—Infection—Capecitabine—prostate cancer	0.000165	0.000947	CcSEcCtD
Ketotifen—Urticaria—Etoposide—prostate cancer	0.000164	0.000941	CcSEcCtD
Ketotifen—Shock—Capecitabine—prostate cancer	0.000163	0.000938	CcSEcCtD
Ketotifen—Abdominal pain—Etoposide—prostate cancer	0.000163	0.000936	CcSEcCtD
Ketotifen—Body temperature increased—Etoposide—prostate cancer	0.000163	0.000936	CcSEcCtD
Ketotifen—Hepatitis—Epirubicin—prostate cancer	0.000162	0.000935	CcSEcCtD
Ketotifen—Thrombocytopenia—Capecitabine—prostate cancer	0.000162	0.000933	CcSEcCtD
Ketotifen—Syncope—Prednisone—prostate cancer	0.000162	0.000933	CcSEcCtD
Ketotifen—Loss of consciousness—Prednisone—prostate cancer	0.000159	0.000914	CcSEcCtD
Ketotifen—Epistaxis—Doxorubicin—prostate cancer	0.000158	0.000909	CcSEcCtD
Ketotifen—Nausea—Estradiol—prostate cancer	0.000158	0.000908	CcSEcCtD
Ketotifen—Vomiting—Mitoxantrone—prostate cancer	0.000157	0.000905	CcSEcCtD
Ketotifen—Hypertension—Prednisone—prostate cancer	0.000156	0.000898	CcSEcCtD
Ketotifen—Rash—Mitoxantrone—prostate cancer	0.000156	0.000898	CcSEcCtD
Ketotifen—Dermatitis—Mitoxantrone—prostate cancer	0.000156	0.000897	CcSEcCtD
Ketotifen—Headache—Mitoxantrone—prostate cancer	0.000155	0.000892	CcSEcCtD
Ketotifen—Insomnia—Docetaxel—prostate cancer	0.000155	0.00089	CcSEcCtD
Ketotifen—Paraesthesia—Docetaxel—prostate cancer	0.000154	0.000884	CcSEcCtD
Ketotifen—Erythema multiforme—Epirubicin—prostate cancer	0.000154	0.000884	CcSEcCtD
Ketotifen—Somnolence—Docetaxel—prostate cancer	0.000152	0.000875	CcSEcCtD
Ketotifen—Hepatitis—Doxorubicin—prostate cancer	0.00015	0.000865	CcSEcCtD
Ketotifen—Insomnia—Capecitabine—prostate cancer	0.00015	0.000862	CcSEcCtD
Ketotifen—Paraesthesia—Capecitabine—prostate cancer	0.000149	0.000856	CcSEcCtD
Ketotifen—Nausea—Mitoxantrone—prostate cancer	0.000147	0.000846	CcSEcCtD
Ketotifen—Infection—Prednisone—prostate cancer	0.000147	0.000843	CcSEcCtD
Ketotifen—Pain—Docetaxel—prostate cancer	0.000146	0.000842	CcSEcCtD
Ketotifen—Pruritus—Etoposide—prostate cancer	0.000146	0.000838	CcSEcCtD
Ketotifen—Shock—Prednisone—prostate cancer	0.000145	0.000835	CcSEcCtD
Ketotifen—Erythema multiforme—Doxorubicin—prostate cancer	0.000142	0.000818	CcSEcCtD
Ketotifen—Pain—Capecitabine—prostate cancer	0.000142	0.000815	CcSEcCtD
Ketotifen—Diarrhoea—Etoposide—prostate cancer	0.000141	0.00081	CcSEcCtD
Ketotifen—Gastrointestinal pain—Docetaxel—prostate cancer	0.00014	0.000805	CcSEcCtD
Ketotifen—Tension—Epirubicin—prostate cancer	0.000139	0.000798	CcSEcCtD
Ketotifen—Nervousness—Epirubicin—prostate cancer	0.000137	0.00079	CcSEcCtD
Ketotifen—Dizziness—Etoposide—prostate cancer	0.000136	0.000783	CcSEcCtD
Ketotifen—Gastrointestinal pain—Capecitabine—prostate cancer	0.000136	0.000779	CcSEcCtD
Ketotifen—Body temperature increased—Docetaxel—prostate cancer	0.000135	0.000778	CcSEcCtD
Ketotifen—Abdominal pain—Docetaxel—prostate cancer	0.000135	0.000778	CcSEcCtD
Ketotifen—Insomnia—Prednisone—prostate cancer	0.000134	0.000768	CcSEcCtD
Ketotifen—Paraesthesia—Prednisone—prostate cancer	0.000133	0.000762	CcSEcCtD
Ketotifen—Urticaria—Capecitabine—prostate cancer	0.000132	0.000757	CcSEcCtD
Ketotifen—Abdominal pain—Capecitabine—prostate cancer	0.000131	0.000753	CcSEcCtD
Ketotifen—Body temperature increased—Capecitabine—prostate cancer	0.000131	0.000753	CcSEcCtD
Ketotifen—Vomiting—Etoposide—prostate cancer	0.000131	0.000753	CcSEcCtD
Ketotifen—Rash—Etoposide—prostate cancer	0.00013	0.000747	CcSEcCtD
Ketotifen—Dermatitis—Etoposide—prostate cancer	0.00013	0.000746	CcSEcCtD
Ketotifen—Headache—Etoposide—prostate cancer	0.000129	0.000742	CcSEcCtD
Ketotifen—Tension—Doxorubicin—prostate cancer	0.000128	0.000739	CcSEcCtD
Ketotifen—Nervousness—Doxorubicin—prostate cancer	0.000127	0.000731	CcSEcCtD
Ketotifen—Syncope—Epirubicin—prostate cancer	0.000127	0.00073	CcSEcCtD
Ketotifen—Loss of consciousness—Epirubicin—prostate cancer	0.000124	0.000715	CcSEcCtD
Ketotifen—Nausea—Etoposide—prostate cancer	0.000122	0.000704	CcSEcCtD
Ketotifen—Hypertension—Epirubicin—prostate cancer	0.000122	0.000702	CcSEcCtD
Ketotifen—Pruritus—Docetaxel—prostate cancer	0.000121	0.000696	CcSEcCtD
Ketotifen—Gastrointestinal pain—Prednisone—prostate cancer	0.000121	0.000694	CcSEcCtD
Ketotifen—Dry mouth—Epirubicin—prostate cancer	0.000118	0.000677	CcSEcCtD
Ketotifen—Syncope—Doxorubicin—prostate cancer	0.000117	0.000675	CcSEcCtD
Ketotifen—Urticaria—Prednisone—prostate cancer	0.000117	0.000674	CcSEcCtD
Ketotifen—Pruritus—Capecitabine—prostate cancer	0.000117	0.000674	CcSEcCtD
Ketotifen—Diarrhoea—Docetaxel—prostate cancer	0.000117	0.000674	CcSEcCtD
Ketotifen—Body temperature increased—Prednisone—prostate cancer	0.000117	0.000671	CcSEcCtD
Ketotifen—Abdominal pain—Prednisone—prostate cancer	0.000117	0.000671	CcSEcCtD
Ketotifen—Loss of consciousness—Doxorubicin—prostate cancer	0.000115	0.000662	CcSEcCtD
Ketotifen—Infection—Epirubicin—prostate cancer	0.000115	0.00066	CcSEcCtD
Ketotifen—Shock—Epirubicin—prostate cancer	0.000114	0.000653	CcSEcCtD
Ketotifen—Diarrhoea—Capecitabine—prostate cancer	0.000113	0.000652	CcSEcCtD
Ketotifen—Dizziness—Docetaxel—prostate cancer	0.000113	0.000651	CcSEcCtD
Ketotifen—Thrombocytopenia—Epirubicin—prostate cancer	0.000113	0.00065	CcSEcCtD
Ketotifen—Hypertension—Doxorubicin—prostate cancer	0.000113	0.00065	CcSEcCtD
Ketotifen—Dizziness—Capecitabine—prostate cancer	0.00011	0.00063	CcSEcCtD
Ketotifen—Dry mouth—Doxorubicin—prostate cancer	0.000109	0.000627	CcSEcCtD
Ketotifen—Vomiting—Docetaxel—prostate cancer	0.000109	0.000626	CcSEcCtD
Ketotifen—Rash—Docetaxel—prostate cancer	0.000108	0.000621	CcSEcCtD
Ketotifen—Dermatitis—Docetaxel—prostate cancer	0.000108	0.00062	CcSEcCtD
Ketotifen—Headache—Docetaxel—prostate cancer	0.000107	0.000617	CcSEcCtD
Ketotifen—Infection—Doxorubicin—prostate cancer	0.000106	0.00061	CcSEcCtD
Ketotifen—Vomiting—Capecitabine—prostate cancer	0.000105	0.000606	CcSEcCtD
Ketotifen—Shock—Doxorubicin—prostate cancer	0.000105	0.000604	CcSEcCtD
Ketotifen—Thrombocytopenia—Doxorubicin—prostate cancer	0.000105	0.000602	CcSEcCtD
Ketotifen—Rash—Capecitabine—prostate cancer	0.000104	0.000601	CcSEcCtD
Ketotifen—Pruritus—Prednisone—prostate cancer	0.000104	0.000601	CcSEcCtD
Ketotifen—Insomnia—Epirubicin—prostate cancer	0.000104	0.000601	CcSEcCtD
Ketotifen—Dermatitis—Capecitabine—prostate cancer	0.000104	0.0006	CcSEcCtD
Ketotifen—Headache—Capecitabine—prostate cancer	0.000104	0.000597	CcSEcCtD
Ketotifen—Paraesthesia—Epirubicin—prostate cancer	0.000104	0.000596	CcSEcCtD
Ketotifen—Somnolence—Epirubicin—prostate cancer	0.000103	0.00059	CcSEcCtD
Ketotifen—Nausea—Docetaxel—prostate cancer	0.000102	0.000585	CcSEcCtD
Ketotifen—Diarrhoea—Prednisone—prostate cancer	0.000101	0.000581	CcSEcCtD
Ketotifen—Pain—Epirubicin—prostate cancer	9.87e-05	0.000568	CcSEcCtD
Ketotifen—Nausea—Capecitabine—prostate cancer	9.84e-05	0.000566	CcSEcCtD
Ketotifen—Dizziness—Prednisone—prostate cancer	9.76e-05	0.000561	CcSEcCtD
Ketotifen—Insomnia—Doxorubicin—prostate cancer	9.66e-05	0.000556	CcSEcCtD
Ketotifen—Paraesthesia—Doxorubicin—prostate cancer	9.59e-05	0.000552	CcSEcCtD
Ketotifen—Somnolence—Doxorubicin—prostate cancer	9.5e-05	0.000546	CcSEcCtD
Ketotifen—Gastrointestinal pain—Epirubicin—prostate cancer	9.44e-05	0.000543	CcSEcCtD
Ketotifen—Vomiting—Prednisone—prostate cancer	9.39e-05	0.00054	CcSEcCtD
Ketotifen—Rash—Prednisone—prostate cancer	9.31e-05	0.000535	CcSEcCtD
Ketotifen—Dermatitis—Prednisone—prostate cancer	9.3e-05	0.000535	CcSEcCtD
Ketotifen—Headache—Prednisone—prostate cancer	9.25e-05	0.000532	CcSEcCtD
Ketotifen—Urticaria—Epirubicin—prostate cancer	9.17e-05	0.000527	CcSEcCtD
Ketotifen—Pain—Doxorubicin—prostate cancer	9.13e-05	0.000525	CcSEcCtD
Ketotifen—Abdominal pain—Epirubicin—prostate cancer	9.13e-05	0.000525	CcSEcCtD
Ketotifen—Body temperature increased—Epirubicin—prostate cancer	9.13e-05	0.000525	CcSEcCtD
Ketotifen—Nausea—Prednisone—prostate cancer	8.77e-05	0.000504	CcSEcCtD
Ketotifen—Gastrointestinal pain—Doxorubicin—prostate cancer	8.73e-05	0.000502	CcSEcCtD
Ketotifen—Urticaria—Doxorubicin—prostate cancer	8.49e-05	0.000488	CcSEcCtD
Ketotifen—Body temperature increased—Doxorubicin—prostate cancer	8.44e-05	0.000486	CcSEcCtD
Ketotifen—Abdominal pain—Doxorubicin—prostate cancer	8.44e-05	0.000486	CcSEcCtD
Ketotifen—Pruritus—Epirubicin—prostate cancer	8.17e-05	0.00047	CcSEcCtD
Ketotifen—Diarrhoea—Epirubicin—prostate cancer	7.9e-05	0.000454	CcSEcCtD
Ketotifen—Dizziness—Epirubicin—prostate cancer	7.63e-05	0.000439	CcSEcCtD
Ketotifen—Pruritus—Doxorubicin—prostate cancer	7.56e-05	0.000435	CcSEcCtD
Ketotifen—Vomiting—Epirubicin—prostate cancer	7.34e-05	0.000422	CcSEcCtD
Ketotifen—Diarrhoea—Doxorubicin—prostate cancer	7.31e-05	0.00042	CcSEcCtD
Ketotifen—Rash—Epirubicin—prostate cancer	7.28e-05	0.000419	CcSEcCtD
Ketotifen—Dermatitis—Epirubicin—prostate cancer	7.27e-05	0.000418	CcSEcCtD
Ketotifen—Headache—Epirubicin—prostate cancer	7.23e-05	0.000416	CcSEcCtD
Ketotifen—Dizziness—Doxorubicin—prostate cancer	7.06e-05	0.000406	CcSEcCtD
Ketotifen—Nausea—Epirubicin—prostate cancer	6.86e-05	0.000394	CcSEcCtD
Ketotifen—Vomiting—Doxorubicin—prostate cancer	6.79e-05	0.000391	CcSEcCtD
Ketotifen—Rash—Doxorubicin—prostate cancer	6.74e-05	0.000387	CcSEcCtD
Ketotifen—Dermatitis—Doxorubicin—prostate cancer	6.73e-05	0.000387	CcSEcCtD
Ketotifen—Headache—Doxorubicin—prostate cancer	6.69e-05	0.000385	CcSEcCtD
Ketotifen—Nausea—Doxorubicin—prostate cancer	6.34e-05	0.000365	CcSEcCtD
Ketotifen—PDE4A—Signaling Pathways—CREBBP—prostate cancer	9.6e-06	6.04e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—APC—prostate cancer	9.58e-06	6.03e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PIK3CG—prostate cancer	9.58e-06	6.03e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PIK3CB—prostate cancer	9.57e-06	6.02e-05	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—IL6—prostate cancer	9.57e-06	6.02e-05	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—IL6—prostate cancer	9.57e-06	6.02e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PIK3CD—prostate cancer	9.56e-06	6.02e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—IGF1—prostate cancer	9.48e-06	5.96e-05	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—PIK3CA—prostate cancer	9.47e-06	5.96e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—EGF—prostate cancer	9.47e-06	5.96e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—IRS1—prostate cancer	9.47e-06	5.96e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—SERPINE1—prostate cancer	9.46e-06	5.95e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—EGFR—prostate cancer	9.43e-06	5.93e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—KRAS—prostate cancer	9.36e-06	5.89e-05	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—TP53—prostate cancer	9.32e-06	5.86e-05	CbGpPWpGaD
Ketotifen—PGD—Metabolism—PIK3CA—prostate cancer	9.21e-06	5.79e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CXCL8—prostate cancer	9.2e-06	5.79e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—GSK3B—prostate cancer	9.19e-06	5.78e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MAP2K1—prostate cancer	9.16e-06	5.76e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—FGF2—prostate cancer	9.16e-06	5.76e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PIK3CD—prostate cancer	9.1e-06	5.73e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—INS—prostate cancer	9.07e-06	5.71e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—NOS3—prostate cancer	9.03e-06	5.68e-05	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—PIK3CA—prostate cancer	9.01e-06	5.67e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—SERPINE1—prostate cancer	9e-06	5.66e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CDKN1B—prostate cancer	8.98e-06	5.65e-05	CbGpPWpGaD
Ketotifen—PGD—Disease—AKT1—prostate cancer	8.98e-06	5.65e-05	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—PIK3CA—prostate cancer	8.96e-06	5.63e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—KRAS—prostate cancer	8.91e-06	5.61e-05	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—AKT1—prostate cancer	8.89e-06	5.59e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CREBBP—prostate cancer	8.88e-06	5.59e-05	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—AKT1—prostate cancer	8.83e-06	5.56e-05	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—AKT1—prostate cancer	8.83e-06	5.56e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CASP3—prostate cancer	8.81e-06	5.54e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—IL2—prostate cancer	8.79e-06	5.53e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—JAK2—prostate cancer	8.78e-06	5.52e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—IGF1—prostate cancer	8.77e-06	5.52e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—IL6—prostate cancer	8.75e-06	5.5e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—EGFR—prostate cancer	8.73e-06	5.49e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—FGF2—prostate cancer	8.71e-06	5.48e-05	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—TP53—prostate cancer	8.66e-06	5.45e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—PIK3CA—prostate cancer	8.6e-06	5.41e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—NOS3—prostate cancer	8.59e-06	5.41e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CCND1—prostate cancer	8.57e-06	5.39e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MDM2—prostate cancer	8.57e-06	5.39e-05	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—IL6—prostate cancer	8.53e-06	5.37e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PTHLH—prostate cancer	8.53e-06	5.37e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TGFBR1—prostate cancer	8.53e-06	5.37e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CTNNB1—prostate cancer	8.49e-06	5.34e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MAP2K1—prostate cancer	8.48e-06	5.33e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—ERBB2—prostate cancer	8.45e-06	5.31e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PIK3CD—prostate cancer	8.42e-06	5.3e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—AKR1C3—prostate cancer	8.39e-06	5.28e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—JAK2—prostate cancer	8.35e-06	5.26e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PRKACB—prostate cancer	8.35e-06	5.25e-05	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—PIK3CA—prostate cancer	8.34e-06	5.25e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PIK3CB—prostate cancer	8.33e-06	5.24e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—SERPINE1—prostate cancer	8.33e-06	5.24e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MMP9—prostate cancer	8.32e-06	5.24e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CDKN1A—prostate cancer	8.29e-06	5.22e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PTEN—prostate cancer	8.27e-06	5.21e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—KRAS—prostate cancer	8.24e-06	5.19e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—PIK3CA—prostate cancer	8.19e-06	5.15e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MDM2—prostate cancer	8.15e-06	5.13e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—THBS1—prostate cancer	8.14e-06	5.12e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PPP3CA—prostate cancer	8.14e-06	5.12e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—AKT1—prostate cancer	8.07e-06	5.08e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—FGF2—prostate cancer	8.06e-06	5.07e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—ERBB2—prostate cancer	8.04e-06	5.06e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ANXA1—prostate cancer	8.02e-06	5.05e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CXCL8—prostate cancer	8.01e-06	5.04e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—NOS3—prostate cancer	7.95e-06	5e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PIK3CB—prostate cancer	7.93e-06	4.99e-05	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—IL6—prostate cancer	7.93e-06	4.99e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—EP300—prostate cancer	7.89e-06	4.96e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PRKCZ—prostate cancer	7.87e-06	4.95e-05	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—AKT1—prostate cancer	7.87e-06	4.95e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CDKN1B—prostate cancer	7.82e-06	4.92e-05	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—AKT1—prostate cancer	7.74e-06	4.87e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—JAK2—prostate cancer	7.73e-06	4.86e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CG—prostate cancer	7.69e-06	4.84e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—SRC—prostate cancer	7.67e-06	4.83e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CASP3—prostate cancer	7.67e-06	4.82e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—IL2—prostate cancer	7.65e-06	4.82e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CXCL8—prostate cancer	7.62e-06	4.8e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—IL6—prostate cancer	7.62e-06	4.79e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PARP1—prostate cancer	7.6e-06	4.78e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—FGFR4—prostate cancer	7.6e-06	4.78e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—PIK3CA—prostate cancer	7.57e-06	4.77e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MDM2—prostate cancer	7.54e-06	4.75e-05	CbGpPWpGaD
Ketotifen—PGD—Metabolism—AKT1—prostate cancer	7.52e-06	4.73e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CALCA—prostate cancer	7.51e-06	4.73e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—VEGFA—prostate cancer	7.47e-06	4.7e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CCND1—prostate cancer	7.46e-06	4.69e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CDKN1B—prostate cancer	7.44e-06	4.68e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—ERBB2—prostate cancer	7.44e-06	4.68e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—STAT3—prostate cancer	7.4e-06	4.66e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CTNNB1—prostate cancer	7.39e-06	4.65e-05	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—AKT1—prostate cancer	7.36e-06	4.63e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PIK3CB—prostate cancer	7.34e-06	4.62e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CXCL12—prostate cancer	7.33e-06	4.62e-05	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—AKT1—prostate cancer	7.32e-06	4.6e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CASP3—prostate cancer	7.3e-06	4.59e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—IL2—prostate cancer	7.29e-06	4.58e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—IL6—prostate cancer	7.25e-06	4.56e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MMP9—prostate cancer	7.24e-06	4.56e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CDKN1A—prostate cancer	7.22e-06	4.54e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PTEN—prostate cancer	7.2e-06	4.53e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CCND1—prostate cancer	7.1e-06	4.47e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CXCL8—prostate cancer	7.05e-06	4.44e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CTNNB1—prostate cancer	7.03e-06	4.43e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—AKT1—prostate cancer	7.03e-06	4.42e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CG—prostate cancer	6.99e-06	4.4e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CASP9—prostate cancer	6.91e-06	4.35e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MMP9—prostate cancer	6.9e-06	4.34e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CDKN1B—prostate cancer	6.89e-06	4.33e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MYC—prostate cancer	6.88e-06	4.33e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CDKN1A—prostate cancer	6.87e-06	4.32e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—EP300—prostate cancer	6.87e-06	4.32e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—TGFB1—prostate cancer	6.86e-06	4.32e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PTEN—prostate cancer	6.86e-06	4.31e-05	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—AKT1—prostate cancer	6.81e-06	4.29e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CD—prostate cancer	6.76e-06	4.26e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CASP3—prostate cancer	6.75e-06	4.25e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—IL2—prostate cancer	6.74e-06	4.24e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—EGFR—prostate cancer	6.72e-06	4.23e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—IL6—prostate cancer	6.71e-06	4.22e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NGFR—prostate cancer	6.69e-06	4.21e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PRKCQ—prostate cancer	6.69e-06	4.21e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—AKT1—prostate cancer	6.69e-06	4.21e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—SRC—prostate cancer	6.68e-06	4.2e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MAP3K7—prostate cancer	6.61e-06	4.16e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CCND1—prostate cancer	6.57e-06	4.13e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—EP300—prostate cancer	6.54e-06	4.11e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CTNNB1—prostate cancer	6.51e-06	4.09e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—VEGFA—prostate cancer	6.5e-06	4.09e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—STAT3—prostate cancer	6.44e-06	4.05e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MMP9—prostate cancer	6.38e-06	4.01e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—FGF10—prostate cancer	6.36e-06	4e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CDKN1A—prostate cancer	6.36e-06	4e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—SRC—prostate cancer	6.36e-06	4e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—KRAS—prostate cancer	6.35e-06	4e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PTEN—prostate cancer	6.34e-06	3.99e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ADRB2—prostate cancer	6.29e-06	3.96e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—JAK2—prostate cancer	6.21e-06	3.91e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—VEGFA—prostate cancer	6.19e-06	3.9e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—AKT1—prostate cancer	6.19e-06	3.89e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—MAP2K1—prostate cancer	6.18e-06	3.89e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CD—prostate cancer	6.14e-06	3.86e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—VAV3—prostate cancer	6.14e-06	3.86e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—STAT3—prostate cancer	6.13e-06	3.86e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TGFBR2—prostate cancer	6.05e-06	3.81e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—EP300—prostate cancer	6.05e-06	3.81e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MYC—prostate cancer	5.98e-06	3.77e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—TGFB1—prostate cancer	5.97e-06	3.76e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ITPR1—prostate cancer	5.95e-06	3.75e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CB—prostate cancer	5.9e-06	3.71e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—SRC—prostate cancer	5.88e-06	3.7e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—EGFR—prostate cancer	5.85e-06	3.68e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PIK3CA—prostate cancer	5.84e-06	3.67e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—VEGFA—prostate cancer	5.73e-06	3.6e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MYC—prostate cancer	5.7e-06	3.58e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IGF1R—prostate cancer	5.69e-06	3.58e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—TGFB1—prostate cancer	5.68e-06	3.58e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—STAT3—prostate cancer	5.67e-06	3.57e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—CXCL8—prostate cancer	5.67e-06	3.56e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—TP53—prostate cancer	5.65e-06	3.55e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—JAK2—prostate cancer	5.64e-06	3.55e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—EGFR—prostate cancer	5.57e-06	3.51e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—KRAS—prostate cancer	5.53e-06	3.48e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—LPL—prostate cancer	5.46e-06	3.43e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—IL2—prostate cancer	5.41e-06	3.41e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PDGFRB—prostate cancer	5.41e-06	3.4e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CB—prostate cancer	5.35e-06	3.37e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MYC—prostate cancer	5.27e-06	3.32e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ITGB3—prostate cancer	5.27e-06	3.32e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—KRAS—prostate cancer	5.26e-06	3.31e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—TGFB1—prostate cancer	5.26e-06	3.31e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—IL6—prostate cancer	5.17e-06	3.25e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—EGFR—prostate cancer	5.16e-06	3.24e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—CXCL8—prostate cancer	5.14e-06	3.24e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ERBB3—prostate cancer	5.11e-06	3.22e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—FGFR2—prostate cancer	5.1e-06	3.21e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PIK3CA—prostate cancer	5.08e-06	3.2e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—IL2—prostate cancer	4.92e-06	3.09e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—TP53—prostate cancer	4.92e-06	3.09e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TERT—prostate cancer	4.9e-06	3.08e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—KRAS—prostate cancer	4.87e-06	3.06e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PIK3CA—prostate cancer	4.84e-06	3.04e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—AKT1—prostate cancer	4.77e-06	3e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—HIF1A—prostate cancer	4.69e-06	2.95e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—TP53—prostate cancer	4.68e-06	2.94e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—LEP—prostate cancer	4.57e-06	2.88e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CAV1—prostate cancer	4.53e-06	2.85e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—IL6—prostate cancer	4.5e-06	2.83e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—KDR—prostate cancer	4.48e-06	2.82e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PIK3CA—prostate cancer	4.47e-06	2.82e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ESR1—prostate cancer	4.37e-06	2.75e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—TP53—prostate cancer	4.33e-06	2.72e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—IL6—prostate cancer	4.28e-06	2.69e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—BAD—prostate cancer	4.26e-06	2.68e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—AKT1—prostate cancer	4.15e-06	2.61e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CG—prostate cancer	4.13e-06	2.6e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—APC—prostate cancer	4.13e-06	2.6e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—EGF—prostate cancer	4.08e-06	2.57e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IRS1—prostate cancer	4.08e-06	2.57e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—IL6—prostate cancer	3.96e-06	2.49e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—GSK3B—prostate cancer	3.96e-06	2.49e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—AKT1—prostate cancer	3.95e-06	2.49e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—INS—prostate cancer	3.91e-06	2.46e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CREBBP—prostate cancer	3.83e-06	2.41e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IGF1—prostate cancer	3.78e-06	2.38e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—EGFR—prostate cancer	3.76e-06	2.37e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—AKT1—prostate cancer	3.66e-06	2.3e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MAP2K1—prostate cancer	3.65e-06	2.3e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CD—prostate cancer	3.63e-06	2.28e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CA—prostate cancer	3.59e-06	2.26e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SERPINE1—prostate cancer	3.59e-06	2.26e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—KRAS—prostate cancer	3.55e-06	2.24e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—FGF2—prostate cancer	3.47e-06	2.19e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NOS3—prostate cancer	3.43e-06	2.16e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—JAK2—prostate cancer	3.33e-06	2.1e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CA—prostate cancer	3.26e-06	2.05e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MDM2—prostate cancer	3.25e-06	2.05e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ERBB2—prostate cancer	3.2e-06	2.02e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CB—prostate cancer	3.16e-06	1.99e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CXCL8—prostate cancer	3.04e-06	1.91e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CDKN1B—prostate cancer	2.97e-06	1.87e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—AKT1—prostate cancer	2.94e-06	1.85e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CASP3—prostate cancer	2.91e-06	1.83e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IL2—prostate cancer	2.9e-06	1.83e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—IL6—prostate cancer	2.89e-06	1.82e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CCND1—prostate cancer	2.83e-06	1.78e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CTNNB1—prostate cancer	2.8e-06	1.76e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MMP9—prostate cancer	2.75e-06	1.73e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CDKN1A—prostate cancer	2.74e-06	1.72e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PTEN—prostate cancer	2.73e-06	1.72e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—AKT1—prostate cancer	2.67e-06	1.68e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—EP300—prostate cancer	2.61e-06	1.64e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SRC—prostate cancer	2.53e-06	1.59e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—VEGFA—prostate cancer	2.47e-06	1.55e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—STAT3—prostate cancer	2.44e-06	1.54e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MYC—prostate cancer	2.27e-06	1.43e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TGFB1—prostate cancer	2.27e-06	1.43e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—EGFR—prostate cancer	2.22e-06	1.4e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—KRAS—prostate cancer	2.1e-06	1.32e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CA—prostate cancer	1.93e-06	1.21e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TP53—prostate cancer	1.87e-06	1.17e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IL6—prostate cancer	1.71e-06	1.07e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—AKT1—prostate cancer	1.58e-06	9.91e-06	CbGpPWpGaD
